<DOC>
	<DOC>NCT00442858</DOC>
	<brief_summary>The aim of the present study was therefore two-fold: 1) to make a retrospective comparison of incidence of non-fatal stroke and cardiac events between a large cohort of patients with confirmed GHD on replacement therapy (including GH) and a control cohort from the general population; 2) to compare the prevalence of DM and cardioprotective medication between the cohorts at the time of questionnaire distribution with adjustment for possible confounders and effect modifiers.</brief_summary>
	<brief_title>Incidence of Cardiovascular Diseases in Patients With Hypopituitarims</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Confirmed GH deficiency Not confirmed GH deficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>cardiac disease</keyword>
	<keyword>cerebrovascular disease</keyword>
	<keyword>GH deficiency</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>hypertension</keyword>
	<keyword>GH therapy</keyword>
	<keyword>GH deficiency and hypopituitarims</keyword>
</DOC>